EFM
E Fund Management’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.8K | Sell |
12,575
-1,145
| -8% | -$6.08K | ﹤0.01% | 386 |
|
|
2025
Q1 | $122K | Buy |
13,720
+1,968
| +17% | +$17.5K | 0.01% | 378 |
|
|
2024
Q4 | $161K | Buy |
+11,752
| New | +$161K | 0.01% | 372 |
|
|
2024
Q2 | – | Sell |
-11,776
| Closed | -$251K | – | 355 |
|
|
2024
Q1 | $251K | Buy |
+11,776
| New | +$251K | 0.02% | 299 |
|
|
2023
Q4 | – | Sell |
-10,709
| Closed | -$172K | – | 322 |
|
|
2023
Q3 | $172K | Buy |
10,709
+159
| +2% | +$2.55K | 0.01% | 265 |
|
|
2023
Q2 | $245K | Buy |
10,550
+911
| +9% | +$21.2K | 0.02% | 248 |
|
|
2023
Q1 | $224K | Sell |
9,639
-1,183
| -11% | -$27.5K | 0.02% | 279 |
|
|
2022
Q4 | $157K | Sell |
10,822
-961
| -8% | -$13.9K | 0.01% | 314 |
|
|
2022
Q3 | $225K | Sell |
11,783
-698
| -6% | -$13.3K | 0.02% | 283 |
|
|
2022
Q2 | $227K | Buy |
+12,481
| New | +$227K | 0.02% | 278 |
|